2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 68298667, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:23]=[CH:22][CH:21]=[C:20]([CH2:24][CH2:25][N:26]2[CH2:30][CH2:29][CH2:28][CH2:27]2)[CH:19]=1.[Cl:31][C:32]1[CH:37]=[C:36](B2OC(C)(C)C(C)(C)O2)[CH:35]=[C:34]([Cl:47])[C:33]=1[OH:48]>CO>[ClH:31].[CH:14]1([C:12]([C:6]2[CH:7]=[N:8][C:9]3[C:4]([C:5]=2[NH:17][C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([CH2:24][CH2:25][N:26]4[CH2:27][CH2:28][CH2:29][CH2:30]4)[CH:19]=2)=[CH:3][C:2]([C:36]2[CH:35]=[C:34]([Cl:47])[C:33]([OH:48])=[C:32]([Cl:31])[CH:37]=2)=[CH:11][CH:10]=3)=[O:13])[CH2:16][CH2:15]1Participants
Procedure
Following general procedure F, (6-bromo-4-(3-(2-(pyrrolidin-1-yl)ethyl)phenylamino)quinolin-3-yl)(cyclopropyl)methanone (41 mg, 0.088 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (38 mg, 0.13 mmol) and the desired compound was dissolved in methanol (4 mL) and HCl (2 mL, 1.25 M in methanol). The mixture was concentrated to obtain the desired product (47 mg, 86% over two steps) as a yellow solid: 1H NMR (500 MHz, CD3OD) δ 9.45 (s, 1H), 8.22 (dd, J=8.8, 1.9 Hz, 1H), 8.02 (d, J=8.8 Hz, 1H), 7.88 (s, 1H), 7.65-7.58 (m, 1H), 7.57-7.54 (m, 1H), 7.48 (s, 1H), 7.41-7.31 (m, 1H), 7.20 (s, 2H), 3.69-3.65 (m, 2H), 3.45-3.38 (m, 2H), 3.19-3.12 (m, 2H), 3.11-3.07 (m, 2H), 2.93-2.86 (m, 1H), 2.15-2.11 (s, 2H), 2.05-2.01 (s, 2H), 1.24-1.16 (m, 4H); ESI MS m/z 546 [C31H29Cl2N3O2+H]+; HPLC 97.8% (AUC), tR=10.83 min.
Sources & evidence
- ORD record
- ord-b46767a9367541f2911f4bf04f5ea93d
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…